HARARE, Nov 11 (Reuters) – Moderna Inc (MRNA.O) has offered to sell its COVID-19 vaccines to the African Union at $7 a shot, head of the Africa Centres for Disease Control John Nkengasong said on Thursday, half the price paid by the United States earlier in the year.
It is also a substantial discount to what other buyers like the European Union have agreed this year, part of a broader trend for drugmakers to sell at lower prices to lower income countries.
“I am happy to say that a dose of the Moderna vaccine will be $7. That is what is being offered to us,” Nkengasong told a weekly virtual media briefing.
Earlier this year, Moderna said its deals outside the United States had been struck at between $22 and $37 per dose. As those did not include a lower income country, this is the first insight into the kind of prices Moderna is prepared to charge poorer countries.
Nkengasong said there was no doubt that a fourth wave of the pandemic was coming to Africa, where only 6% of the eligible population has been fully vaccinated.
Africa has to date recorded 8.5 million cases and 220,000 deaths, said Nkengasong.
Reporting by MacDonald Dzirutwe; Editing by Jon Boyle and Jan Harvey
Our Standards: The Thomson Reuters Trust Principles.